Roth Capital analyst Eric Handler raised the firm’s price target on Cinemark (CNK) to $35 from $34 and keeps a Buy rating on the shares after the company reported “strong outperformance” in a soft Q3 box office environment. Having paid off its pandemic related debt and reduced its net leverage, Cinemark has “significant financial flexibility” to reinvest in the business, return capital to shareholders, and explore M&A, the analyst tells investors.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CNK:
